Phospholipase A2 Producing Bacteria and Pre-Term Labor
1 other identifier
observational
60
1 country
1
Brief Summary
The purpose of this study is to better understand (1) if phospholipase A2 producing microorganisms and cytokines (IL-1, IL-4, IL-6, IL-10, and IL-13) are associated with premature labor (2) if pregnant teens are more likely to have phospholipase A2 producing bacteria than a pregnant adults and (3) if there is a difference in the cytokines between pregnant teens and adults.We hypothesize that phospholipase producing microorganisms may trigger the onset of premature labor. The following are hypothesized: (a) The microorganism cultured should show high activities of phospholipase A2 (b) The cervical length measurement predictive value should correspond to the gestation age at term (c) Vaginal flora of teen will be more susceptible to colonization with higher phospholipase A2 producing bacteria than that of an adult (d) The maternal genotype contribution to the concentration of IL-1, IL-4, IL-6, IL-10, IL-13, and TNF-alpha during the first trimester of pregnancy in teens is different in the production of inflammatory cytokines and modulators(e) The maternal genotype of teens therefore influences the production of phospholipase A2 and causes an increase in preterm delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2009
CompletedFirst Posted
Study publicly available on registry
March 4, 2009
CompletedStudy Start
First participant enrolled
August 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJuly 15, 2011
July 1, 2011
1.3 years
March 3, 2009
July 14, 2011
Conditions
Eligibility Criteria
Obstetric patients in West Virginia
You may qualify if:
- Gestational age \<34 weeks
- Singleton gestation
- Urinalysis and urine culture collected via clean catch
- Age range 14 - 45
- Patient receiving prenatal care at CAMC Women's Medicine Center
You may not qualify if:
- In labor or with uterine contractions
- Known fetal anomalies
- Cerclage
- Dark amniotic fluid suggestive of previous bleeding
- Multiple gestation
- Known unbalance chromosomal complement
- Pregnant patient with prior history of excisional cervical biopsy (either cold knife, loop electrosurgical excision procedure, or laser conization)
- Patient with mullerian anomaly
- Patient with 2 or more D\&E secondary to spontaneous or induced abortion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charleston Area Medical Center/West Virginia University
Charleston, West Virginia, 25304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Byron C Calhoun, MD
West Virginia Univeristy/Charleston Area Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 3, 2009
First Posted
March 4, 2009
Study Start
August 1, 2009
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
July 15, 2011
Record last verified: 2011-07